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1. Brief Summary of Plans: 
Based on preliminary data obtained in growth studies, no significant 
changes in our research plan are anticipated. Specific Aim #1 will be 
completed within the first 6 months of this next year (-02) and the 
experiments within Specific Aim 2; to determine the influence of 
hemodynamic preconditioning on maintenance of endothelial integrity in 
response to shear stress; and Specific Aim 3; to examine platelet and 
monocyte adherence on hemodynamically pre -conditioned endothelial cells; 
will be initiated in year -02 both at UTHSCSA and GIT as outlined in the 
original proposal. 
2. Current Studies: 
The initial seven months of this study have concentrated on 
characterization of the growth of bovine aortic endothelial cells (BAEC) and 
porcine aortic endothelial cells (PAEC) on several of the proposed substrates. 
These substrates include 1 micron pore polyester mesh, 1 micron pore 
dacron, a nonporous polyester film, and nonporous polystyrene (culture 
ware plastic). Additionally, endothelial cell replication on these surfaces 
was examined using either the native surface or subsequent to collagen 
and/or fibronectin coating. 
Endothelial cells were seeded at a density of 10 4 cell/cm 2 on the 
respective substrates. Cell replication was monitored on days 1,3,5,7 after 
seeding by cell counting, 3 H-thymidine incorporation, and 3 H-thymidine 
autoradiography. 
The results indicate that endothelial cells seeded upon noncoated 
polyester mesh, dacron mesh, or nonporous polyester exhibit a slower 
growth rate and attain a lower maximum number and density relative to 
cells plated on standard polystyrene culture ware. Either collagen and/or 
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fibronectin coating of these surfaces allowed endothelial cells to achieve full 
confluence by day 5 at a number and density similar to that observed on 
standard culture surfaces. In experiments utilizing coated surfaces, 3 H - 
thymidine incorporation and autoradiograpic labeling were maximum at 
days 1 and 3 and sharply decreased to a minimum plateau at days 5 and 7. 
Current efforts involve examining endothelial cell growth on uncoated 
vs collagen and/or fibronectin coated mesh under either steady state or 
pulsatile shear stress conditions. Secondly, current studies are now 
extending to evaluate PAEC and BAEC growth on expanded 
polytetrafluoroethylene (ePTFE). This studies were delayed due to difficulty 
in obtaining the desired material from the original proposed source (W.C. 
Gore and Associates). We now have ePTFE provided to us by Shiley, Inc., 
Irvine, CA. 
The most significant achievements of the current year involve 
characterization of endothelial cell growth on several potential vascular 
graft materials and the attainment of a confluent endothelial cell monolayer 
on the porous polyester mesh within 5 days postseeding. These basic 
accomplishments allow us to proceed with the major objectives of this 
proposal. Specifically, studies examining the influence of hemodynamic 
shear stress on cell replication, cell to cell and cell to substrate interactions, 
and platelet and monocyte adherence to .endothelium cultured on these 
potential graft surfaces can now proceed. Finally, these results indicate the 
feasibility of attaining a totally preendothelialized vascular graft which, 
potentially, may exhibit superior nonthrombogenicity and patency to 
currently available small diameter vascular grafts. 
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